Amiodarone as an Antiarrhythmia Therapy can Induce Acute Renal Failure in Patiens with SupraventricularTachycardia (SVT): A Rare Case Report
DOI:
https://doi.org/10.25077/jka.v14i3.2674Abstract
Amiodarone is classified as a class III antiarrhythmic agent that primarily inhibits adrenergic stimulation by blocking alpha and beta-adrenergic receptors. This drug also affects sodium, potassium, and calcium channels and prolongs the action potential and refractory period in myocardial tissue. Amiodarone, a drug well known for its wide range of side effects, can also affect the kidneys. The incidence of amiodarone-induced acute kidney failure is rare. There are limited studies regarding kidney injury caused by amiodarone. It has been reported a 45-year-old woman was admitted with leiomyoma and was scheduled for surgery. During hospitalization, the patient complained of palpitations that had been continuously present for one day. Electrocardiographic examination showed supraventricular tachycardia. The patient received intravenous amiodarone therapy followed by oral amiodarone. Renal function test results showed a decline after the patient received amiodarone therapy for 24 hours. The supraventricular tachycardia converted to normal sinus rhythm. After amiodarone was discontinued for several days, renal function returned to normal significantly.
Keywords: acute kidney injury, amiodarone, renal toxicity
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Melany Nurjanah, Haryadi Haryadi

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors retain copyright and grant the Jurnal Kesehatan Andalas right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike (CC BY-SA 4.0) license that allows others to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material) the work for any purpose, even commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kesehatan Andalas.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kesehatan Andalas.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).










